COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response - Tong, Sherry; Litwin, Sean M.; Epel, Elissa S.; Lin, Jue; Drury, Stacy S.; Hecht, Frederick M.; Robinson, James E.; Prather, Aric A.; Norton, Elizabeth B. (Vaccine, 2025)
Keywords: Adult; Allergy and Immunology; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; CD4 antigen; CD4-Positive T-Lymphocytes - immunology; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; Cells; COVID-19; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 vaccine; COVID-19 vaccines; COVID-19 Vaccines - immunology; Cytokines; Cytokines - immunology; Cytokines - metabolism; FDA approval; Female; Humans; Immune response; Immune response (cell-mediated); Immune system; Immunity (Disease); Immunity, Cellular; Immunological memory; Immunoregulation; Infections; Lymphocytes T; Male; Middle Aged; mRNA; mRNA vaccines; Proteins; Questionnaires; SARS-CoV-2; SARS-CoV-2 - immunology; Severe acute respiratory syndrome coronavirus 2; Sex differences; Sex Factors; Sociodemographics; Spike Glycoprotein, Coronavirus - immunology; Stains & staining; T-cell; Vaccination; Vaccines; Vectors (Biology); Viral diseases; Viral infections; Young Adult; United States--US; San Francisco California; California; COVID-19 vaccine; Sex differences; SARS-CoV-2; T-cell